Genentech
LUCENTIS
Manufacturer:
Genentech
Name:
LUCENTIS
HCPCS Code Descriptor:
Injection, ranibizumab, 0.1 mg
Category:
J Code
HCPCS:
J2778
NDC(s):
50242-0082-03, 50242-0080-02, 50242-0080-03, 50242-0082-02
Primary Type:
Opthalmic
Generic Status:
Single-Source
Route of Administration:
Intraocular
About:
LUCENTIS is an Opthalmic drug manufactured by Genentech and administered via the Intraocular route of administration. The J Code: J2778 is aligned to the drug LUCENTIS.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/08
HCPCS Effective Date:
1/1/08
HCPCS Short Description:
Ranibizumab injection
Billing and Coding Guide:
https://www.lucentis.com/content/dam/gene/accesssolutions/pdfs/coding/LUCENTIS-Billing-Coding-for-ALL.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation